Skip to content

Drug interactions

Aprepitant + Isavuconazonium

Severity: Minor

Aprepitant and Isavuconazonium: minor interaction.

Last updated

For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.

Summary

Isavuconazole is a CYP3A4 substrate and moderate inhibitor; aprepitant is a substrate and moderate inducer/inhibitor. The combined effect on isavuconazole is uncertain, and a decrease in antifungal exposure is theoretically possible with repeated aprepitant dosing.

What this interaction means in plain words

Aprepitant and Isavuconazonium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.

Aprepitant belongs to Gastrointestinal Tract; Isavuconazonium belongs to Anti Fungals.

Evidence level: Low

Why it happens

Aprepitant has mixed CYP3A4 inhibitory and inductive effects; the net effect on isavuconazole is not established.

What to do

No empiric adjustment is needed. Monitor clinical response to antifungal therapy and aprepitant tolerability.

What to ask your pharmacist

  • Is there anything I should notice while taking both?
  • Do I need to tell my doctor at the next visit?

Bring a full list of your medicines, including over-the-counter products, supplements and herbal remedies, to every pharmacy visit.

Pro+ members

Unlock the full page

Create an account and start a Pro+ trial to unlock the full management advice for Aprepitant and Isavuconazonium, the additional notes, the evidence detail and the whole-prescription interaction checker.

  • Full clinical management advice
  • Additional notes
  • Evidence detail
  • Interaction checker for a whole prescription

Try Pro+ free for 7 days on the web. No card needed.

Frequently asked questions

Can I take Aprepitant with Isavuconazonium?

MediHelp rates the interaction as minor. Aprepitant and Isavuconazonium have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Isavuconazole is a CYP3A4 substrate and moderate inhibitor; aprepitant is a substrate and moderate inducer/inhibitor. The combined effect on isavuconazole is uncertain, and a decrease in antifungal exposure is theoretically possible with repeated aprepitant dosing.

How serious is the interaction between Aprepitant and Isavuconazonium?

MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No empiric adjustment is needed. Monitor clinical response to antifungal therapy and aprepitant tolerability.

What other medicines interact with Aprepitant?

MediHelp also lists interactions of Aprepitant with, for example, Lomitapide, Pimozide, Avapritinib. The full list is on the Aprepitant page.

Full monographs, dosing and an interaction checker in the MediHelp app

Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.

Browse A–Z · Drug interactions

Get the app Sign in